ロード中...

Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With Glioblastomas

The purpose of this study was to perform a meta-analysis examining the association of isocitrate dehydrogenase (IDH)1/2 mutations with overall survival (OS) and progression-free survival (PFS) in patients with glioblastomas. Medline, Cochrane, EMBASE, and Google Scholar were searched from inception...

詳細記述

保存先:
書誌詳細
出版年:Medicine (Baltimore)
主要な著者: Chen, Jun-Rui, Yao, Yu, Xu, Hong-Zhi, Qin, Zhi-Yong
フォーマット: Artigo
言語:Inglês
出版事項: Wolters Kluwer Health 2016
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4782833/
https://ncbi.nlm.nih.gov/pubmed/26945349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000002583
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!